Korean Government Accelerates Support For Homegrown Biosimilars
This article was originally published in PharmAsia News
Executive Summary
SEOUL - While South Korea's FDA is getting ready to release its initial version of registration guidelines for biosimilars, the Ministry for Knowledge Economy said it would use public funds to help local pharma and biotech companies to compete in the biosimilar arena